Gunasekera, Kenneth S.
Zelner, Jon
Becerra, Mercedes C.
Contreras, Carmen
Franke, Molly F.
Lecca, Leonid
Murray, Megan B.
Warren, Joshua L.
Cohen, Ted
Funding for this research was provided by:
National Institutes of Health (T32GM007205)
Fogarty International Center (D43TW010540)
National Institute of Allergy and Infectious Diseases (U01AI057786, U19AI076217)
Article History
Received: 1 April 2020
Accepted: 9 July 2020
First Online: 2 September 2020
Ethics approval and consent to participate
: The study protocol for the prospective molecular epidemiology investigation was approved by the Harvard University Institutional Review Board (Ref. No. 19332). The study protocol for data collection and spatial analyses of cases notified to the Peru National TB Program from 2005 to 2007 was approved by the Research Ethics Committee of the National Institute of Health of Peru (Ref. No. 085-2007). Consent was not required as this is a secondary data analysis of previously published, de-identified data.
: Not applicable
: The authors declare that they have no conflicts of interest.